-+ 0.00%
-+ 0.00%
-+ 0.00%

Kazia Therapeutics Announces Pricing Of $40M Underwritten Offering Of ADSs And Pre-Funded Warrants

Benzinga·08/31/2026 11:12:38
Listen to the news

https://www.sec.gov/Archives/edgar/data/1075880/000121390026095303/ea0303882-424b5_kazia.htm